Femasys Raises $10.2M in Series B

What does Femasys do?

Femasys, is a startup which engages in research and development of medical devices for women’s healthcare mainly for use in the physician’s office. One of its product’s is FemVue Saline-Air Device, which creates and delivers an alternate patterns of air and saline as a continous stream which helps physicians assess their patient’s fallopian tubes; and the FemChec Pressure Management Device, which controls the maximum applied pressure while performing hysterosalpingogram. It also offers FemCerv, which is an endocervical curettage device for collecting a non- contaminated tissue sample for screening in cervical cancer. It mainly serves customers in USA.

How much Femasys was funded?

Femasys, raised $10.2 M in Series B funding from Mario Family Funds, Salem Partners and Legacy Capital Partners.

Previous funding

• $1.8M in Venture funding on June 10, 2009 from undisclosed ventures.
• $1.1M in Venture funding on August 27, 2010 from undisclosed ventures.
• $641.5k in Venture funding on June 22, 2011 from undisclosed ventures.
• $1.8M in Venture funding on September 20, 2011 from undisclosed ventures.
• $1M in Venture funding on June 8, 2012 from undisclosed ventures.
• $180k in Venture funding on September 23, 2013 from undisclosed ventures.

What is next for Femasys?

Femasys is pleased to have the support of the group of investors in the latest round of funding. This investment will enable Femasys to invest in programs and people  necessary for achieving the IDE- Investigational Device Exemption milestone for FemBloc and for expanding commercially all over the world and to allow women access better options when it is about managing their health needs.

More about Femasys

Femasys was founded in 2004 by Kathy Lee-Sepsick. It has its headquarters in Suwanee, GA. This is a privately held corporation which is committed to advancing women’s healthcare all over the world by expanding the options of medical devices for women’s healthcare.